Skip to main content

Digital Library

Summit Therapeutics

Ivonescimab

Clinical Trials

Publications

Sign Up for Updates

For further information on how we protect your information, please refer to our Privacy Policy.

*Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

© Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).

Digital Library

This library is for healthcare professionals/members of the media/investors only. Click “continue” if you’re a healthcare professional/member of the media/investor.